The first product designed to prevent pressure injury progression.
Embedded Files
A SILK BIOMATERIALS COMPANY
DuraDerma is a topical silk-fibroin gel that strengthens skin — addressing a $26.8 Billion U.S. burden for hospital-aqcuired pressure injuries (PI) for which there is currently no labeled prevention of progression product.
PRESSURE INJURIES
Pressure injuries are progressive and a key source of infection.
Pressure injuries are wounds that form in immobilized patients. There are no current products labeled to reduce the risk of forming a pressure injury nor to reduce the risk of progression of early-stage pressure injuries.
Built for the people who move this market
A clear next step for every stakeholder — capital, clinical adoption, or commercial partnership.
THE PRODUCT
DuraDerma safely strengthens skin
A topical gel of medical-grade silk fibroin, applied alongside standard of care to at-risk points of body contact, to reinforce intact skin and enhances resilience against mechanical stress and shearing forces that drive pressure injury.
Preventative, not reactive. Acts on intact skin — unlike dressings and NPWT used on open wounds.
Intended for twice daily application by a provider to high-risk contact points in bedridden, immobilized patients.
Augments standard of care to improve efficacy rather than replacing existing protocols.
THE OPPORTUNITY
A large, costly, structurally under-served market
In the U.S. more than 15 million patients are at-risk of developing a pressure injury and more than 2.5 million cases occur each year1 resulting in >$26.8B in care costs (>$70B globally, >100M at-risk patients). Late-stage injuries cost up to $44,000 per case.
Reducing the risks of developing a pressure injury or progression of an early-stage injury in at-risk patients is one of the largest unmet medical needs in the advanced wound care market.
Fundraising
Now raising a seed round to obtain initial marketing clearance from U.S. FDA
$2.5M seed to support initial registration of DuraDerma and prepare for commercialization.
Page updated
Report abuse